Resources

Ontario Returns to School: An Overview of the Science

Product: — Science Table

Re-Opening School Protocols Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Last Updated: January 12, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: January 8, 2022

Protecting Vulnerable Patients From the COVID‑19 Variant Omicron in Hospital

Product: — Evidence Synthesis Network

Hospital Infection Control Transmission Vulnerable Groups Vulnerable Sub-populations

esnetwork.ca Last Updated: January 6, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: December 22, 2021

Impact of Physical Activity on Mental Health Outcomes During The COVID‑19 Pandemic, Including In At-Risk Populations

Product: — Evidence Synthesis Network

Mental Health & Well-being Mental Wellness Physical Wellness Vulnerable Groups Vulnerable Sub-populations

esnetwork.ca Last Updated: December 16, 2021

Effective Approaches for Delivering Virtual Care to Adults with Mental Health and Addiction Disorders

Product: — Evidence Synthesis Network

Health Equity & Social Determinants of Health Health Status Mental Health & Well-being Mental Wellness Telecare Virtual Care

esnetwork.ca Last Updated: November 25, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

covid19-sciencetable.ca Last Updated: November 24, 2021

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Last Updated: November 24, 2021

Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

covid19-sciencetable.ca Last Updated: November 24, 2021

Design Strategies To Prevent Respiratory Infection In Congregate Care Settings

Product: — Evidence Synthesis Network

Community Prevention & Transmission Infectious Diseases & Clinical Care Practice Guidelines Public Prevention Transmission

esnetwork.ca Last Updated: November 4, 2021